QTRX

Quanterix (QTRX)

About Quanterix (QTRX)

Quanterix Corp. engages in the development of ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. Its products and services include Simoa Assay Kits, HD-X analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, 2470 Arrayer, Simoa Accelerator Laboratory, Uman NF-Light, and Homebrew -Custom Assay Development. The company was founded by Nicholas J. Naclerio and David R. Walt in April 2007 and is headquartered in Billerica, MA.

Details

Daily high
$6.20
Daily low
$5.77
Price at open
$5.97
52 Week High
$8.77
52 Week Low
$4.05
Market cap
284.5M
Dividend yield
0.00%
Volume
567,295
Avg. volume
729,243
P/E ratio
-2.61

Quanterix News

Details

Daily high
$6.20
Daily low
$5.77
Price at open
$5.97
52 Week High
$8.77
52 Week Low
$4.05
Market cap
284.5M
Dividend yield
0.00%
Volume
567,295
Avg. volume
729,243
P/E ratio
-2.61